Phase 2 Dose-Finding Study of JTT-305 in Patients with Primary Osteoporosis

Authors
Category Primary study
Registry of TrialsJapan Pharmaceutical Information Center
Year 2009
INTERVENTION: Intervention name : JTT‐305 Dosage And administration of the intervention : Oral Control intervention name : Placebo Dosage And administration of the control intervention : Oral CONDITION: Primary Osteoporosis PRIMARY OUTCOME: Percentile change in lumbar spine BMD SECONDARY OUTCOME: Bone turnover markers INCLUSION CRITERIA: ‐ More than 5 years since menopause ‐ < 70% of YAM at lumbar spine ‐ < 80% of YAM at lumbar spine with one mild vertebral fracture
Epistemonikos ID: 98739ed5326147413820faf46583be5bb4ad18fa
First added on: Aug 22, 2024